Abstract
Purpose:
Although fundus photography is extensively used in ophthalmology, refraction prevents accurate distance measurement on fundus images, as the resulting scaling differs between subjects due to varying ocular anatomy. We propose a PARaxial Optical fundus Scaling (PAROS) method to correct for this variation using commonly available clinical data.
Methods:
The complete optics of the eye and fundus camera were modeled using ray transfer matrix formalism to obtain fundus image magnification. The subject's ocular geometry was personalized using biometry, spherical equivalent of refraction (RSE), keratometry, and/or corneal topography data. The PAROS method was validated using 41 different eye phantoms and subsequently evaluated in 44 healthy phakic subjects (of whom 11 had phakic intraocular lenses [pIOLs]), 29 pseudophakic subjects, and 21 patients with uveal melanoma.
Results:
Validation of the PAROS method showed small differences between model and actual image magnification (maximum 3.3%). Relative to the average eye, large differences in fundus magnification were observed, ranging from 0.79 to 1.48. Magnification was strongly inversely related to RSE (R2 = 0.67). In phakic subjects, magnification was directly proportional to axial length (R2 = 0.34). The inverse relation was seen in pIOL (R2 = 0.79) and pseudophakic (R2 = 0.12) subjects. RSE was a strong contributor to magnification differences (1%–83%). As this effect is not considered in the commonly used Bennett–Littmann method, statistically significant differences up to 40% (mean absolute 9%) were observed compared to the PAROS method (P < 0.001).
Conclusions:
The significant differences in fundus image scaling observed among subjects can be accurately accounted for with the PAROS method, enabling more accurate quantitative assessment of fundus photography.
Fundoscopic imaging is one of the most frequently used methods to assess the interior structures of the eye. In addition to visualizing retinal pathology such as diabetic retinopathy,
1 the resulting images can also be used to measure the distance between retinal structures. For example, in ocular oncology the distances between the optic disk, macula, and tumor are used in radiation treatment planning
2,3 (
Fig. 1A). Additionally, lesion size is measured to determine disease progression in patchy chorioretinal atrophy
4 (
Fig. 1B), and optic disk size is used in the assessment and diagnosis of glaucoma patients.
5,6 However, as these images are formed by light rays that pass through the lens and cornea, changes in their optical properties will result in differences in magnification of fundus images,
7 as illustrated in
Figure 1C. As a result, fundus photographs cannot be used for accurate distance measurements, unless they are corrected for these optical effects.
In the 1980s, Littmann and Bennett proposed a method to correct for this scaling difference in fundus photographs acquired with a specific Zeiss fundus camera
8–10:
\begin{eqnarray*}
{d_{true}} = {c_{camera}}*\left( {0.01306 *\left( {AL - 1.82} \right)} \right) * {d_{camera}}
\end{eqnarray*}
where dtrue is the true retinal size of an object, ccamera is a camera-specific constant, AL is the axial length of the eye, and dcamera is the image size on the camera. Thus, in the Bennett–Littmann method, the image magnification scales linearly with the axial length.
Although the Bennett–Littmann method has been widely used
11–13 and has significantly improved the accuracy of fundus-based measurements, it has some limitations. First, the method is based on the telecentric camera design employed by Zeiss in the 1980s.
8 Telecentricity implies that changing the camera focus, which is required to correct for the patient's refraction, has no effect on the image size.
14 However, current fundoscopy cameras are often not telecentric,
15 invalidating the assumption that scaling factor
dcamera is independent of the patient's refraction. Second, the method is inaccurate for ametropic eyes, as the magnification caused by the converging or diverging light rays between the eye and camera in these patients is ignored. Third, although the method corrects for differences in axial length, which have the strongest impact on magnification, differences in other anatomical elements such as corneal curvature are neglected.
16 Finally, the Bennett–Littmann method is not applicable to eyes with an intraocular lens (IOL), as ocular optics are changed by lens implantation.
17 The impact of these limitations is currently not known, as the Bennett–Littmann method has not been thoroughly validated.
In this study, we aimed to resolve these limitations of the Bennett–Littmann method by developing a patient-specific optical model of the eye and camera: the PARaxial Optical fundus Scaling method (PAROS). We extensively validated this model with different optical eye phantoms and sequential ray tracing. Subsequently, the differences in image scaling between the PAROS method and the Bennett–Littmann method in eyes with and without a phakic or pseudophakic IOL and the impact of potential limitations of the Bennett–Littmann method were assessed. Finally, we explored the possible clinical impact of the PAROS method on optic disk measurement and uveal melanoma treatment planning. We hypothesized that accounting for the abovementioned limitations in a full optical model of the eye and camera will result in significantly more accurate measurements on fundus photographs.
The results of the camera calibration, eye phantom validation, and sequential ray-tracing validation are presented first. Thereafter, the magnification is calculated for the pooled patient group, followed by a breakdown of the impact of different parts of the model on total magnification. Finally, the clinical impact of correcting fundus measurements using the PAROS method is discussed.
The groups with phakic, pseudophakic, and uveal melanoma affected eyes were pooled to calculate magnification, resulting in 94 eyes of which 29 were pseudophakic and 65 phakic. The variations in age (17–80 years), RSE (−7.1 to 5.1 D), axial length (20.5–30.4 mm), corneal topography, and anterior chamber depth were substantial. There were some differences between the groups. The mean ages in the uveal melanoma and pIOL groups were higher than in the phakic group, explaining the thicker lenses in these patients. As expected, the anterior chamber was deeper than average in the pseudophakic subjects and less deep in the pIOL subjects.
The magnification relative to the average eye ranged between 0.79 and 1.48. Relative magnification was inversely proportional to spherical equivalent (
R2 = 0.67) (
Fig. 5A) and was not related to axial length in the complete group (
R2 = 0.002) (
Fig. 5B). This relation to axial length was directly proportional in phakic (
R2 = 0.34), but inversely proportional in pseudophakic (
R2 = 0.12) and pIOL (
R2 = 0.79) subjects. Relative magnification as corrected by the PAROS method was statistically significantly different to no correction (
P < 0.001) and to the Bennett approximation (
P < 0.001; mean absolute difference, 9%; range, −38 to 40%) in paired samples
t-tests.
In the model, two distinct contributors to these magnification differences can be discerned: ocular anatomy and camera setup. On average, approximately 47% (range, 1%–99%) of the magnification could be attributed to the ocular anatomy (
Fig. 6A). The relation between the magnification caused by the ocular anatomy and axial length is inversely proportional, similar to the method by Bennett et al.
10 The inclusion of the optical effect of all ocular surfaces as opposed to only axial length led to significant differences between the ocular anatomy–induced magnification in the PAROS method and the total magnification according to the Bennett method (
P < 0.001, paired samples
t-test). The other contribution to the magnification differences was the impact of the camera setup, which is influenced by the patient's RSE. This impact was on average 45% of the observed relative magnification (range, 1%–83%) (
Fig. 6B) and was inversely proportional to spherical equivalent (and thus directly proportional to axial length).
In this study, we showed that the scaling of fundus images can differ up to 50% between patients. These scaling differences can be accurately modeled for paraxial applications using the PAROS method, which is based on the ray transfer matrix formalism. We also showed that this method can be used to correct fundus distances measured on fundoscopy pictures and showed the potential impact in the context of uveal melanoma treatment planning and optic disk categorization.
As PAROS uses a generic camera model, it can easily be adapted to other classic fundus cameras. The eye phantoms used for the calibration are constructed with inexpensive off-the-shelve optical components, which enables a straightforward calibration. For contact-based fundus cameras, such as the Panoret,
35 one additional modification must be made to the model, as there is liquid instead of air between the cornea and lens, which strongly impacts the refraction at the anterior cornea surface.
36 However, as the code for PAROS is publicly available at Github (
https://github.com/MREYE-LUMC/PAROS), together with a table of known camera calibration constants, such a modification is easily made.
The PAROS method has been validated in two distinct ways. First, the mathematical description, together with the used paraxial approximation and implementation in Python, was validated by comparing the magnification of the method to full sequential ray tracing in OpticStudio for 50 eyes. The negligible (below 0.1%) differences show the mathematical correctness of the developed model. Second, the complete methodology was validated in a set of 41 phantom eyes. The small (below 3.3%) differences between measured and predicted magnification are likely attributable to the difficulty in positioning the lenses inside the phantom eye with submillimeter precision. Although the method can thus be accurately used to assess fundus image scaling, the used ray transfer formalism is only valid for the central retina. For more peripheral measurements, larger differences can be expected, which could be corrected using full sequential ray tracing.
37
The Bennett–Littmann method uses only the axial length of the eye to calculate magnification.
8–10 Due to technological advances in the past three decades, the paraxial optical characteristics of all optical elements of the eye can be included in the proposed mathematical description. As a result, the incorporation of this additional anatomical information leads to a significant improvement of the estimation of the magnification induced by the eye compared to the Bennett–Littmann method. However, the combined modeling of the eye and camera revealed that the patient's RSE is a more relevant source of variation in magnification between subjects, as the camera setup is another main contributor to magnification and is strongly affected by RSE, showing that the camera setup used is not telecentric. Although the effect of ametropia on fundus image scaling was described earlier by Lotmar,
38 it did not result in an update of the Bennett–Littmann method. The study by Knaapi et al.
11 constitutes the only in vivo verification of the Bennett–Littmann method. However, when this study is retrospectively evaluated, a negative correlation between prediction error and RSE can be observed, as is expected the light of the PAROS method. The observation that this significant factor contributing to the variation in fundus image scaling has been missed for such a long time emphasizes the importance of robust end-to-end validation.
The PAROS method can be applied in both phakic and pseudophakic eyes, as well as in eyes with a pIOL implant, which is a significant extension compared to the earlier method, which was developed only for phakic eyes. The different associations found for phakic and pseudophakic subjects are caused by the IOL, whose power is selected to correct for the subject's preoperative RSE, breaking the natural dependence of RSE on the axial length of the eye. It was implemented only for eyes with astigmatism <3 D; this method can be easily extended for eyes with larger astigmatism, but in these cases the corneal refraction is dependent on the angle between the cornea and the light rays. The proposed model relies on clinical measurements of the eye, which always have some uncertainties.
30 However, these uncertainties have limited impact on the calculated magnification, as is shown by increasing the axial length or corneal curvature by 0.1 mm or the RSE by 0.5 D, which resulted in respective 0.5%, 0.6%, and 3.3% changes in magnification for the Escudero-Sanz–Navarro eye model. As the exact optical properties of the lens, including curvature and spatially varying index of refraction, are not easily determined clinically, we fitted the curvature of the posterior lens surface so that the RSE of the eye model would match the clinically measured RSE. Although this will introduce a small error in the anatomical description of the eye, a recent study showed that variations in the optical properties of the lens have a negligible effect on the image scaling.
39 The most important variable factor in the camera model that cannot be measured is the distance between the eye and the camera. Extending the eye–camera distance by 5 mm led to an absolute magnification change of 1% on average (range, −6% to 2%) in the patient group, which indicates that this uncertainty is fairly small.
In its current implementation, PAROS uses a relatively simple camera model consisting of a condenser lens to calculate the image size on the image plane. This model is not fully representative of optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO), as these imaging modalities do not focus light rays onto an imaging plane but instead rely on interference of reflected light rays to visualize anatomy.
36,40 As a result, a different dependence on the subject's refraction, the most prominent factor in the magnification of classical fundus cameras, is expected. The PAROS method could be extended to these types of imaging modalities, but doing so would require further validation to ensure accurate mathematical description of the camera. Interestingly, various OCT studies report a similar variation (up to 25%
41,42) of image scaling as found in this study (
Fig. 6A), suggesting a similar clinically relevant impact of correcting for magnification differences.
The clinical relevance of correcting the scaling of fundus images depends on the measurement performed and the acceptable uncertainties. Because clinicians are aware of the scaling difference on fundoscopy images, these measurements are currently not used independently but are compared with other clinical data, or distances are expressed in amount of optic disk diameters.
31,43,44 This can be ameliorated through dependable correction of fundus scaling. We showed two applications in which correction of fundus photographs can have a significant impact. In the presented uveal melanoma case, there was a 50% probability that the use of uncorrected fundus images would result in clinically significant position errors in radiation therapy planning when no other information would be included to determine the tumor location. In the context of ocular oncology, it is important to note that fundus measurements are always complemented by other modalities such as ultrasound and magnetic resonance imaging.
3,45,46 For highly myopic patients, we showed that in 15% of patients RSE change led to an apparent patchy chorioretinal atrophy lesion size change corresponding to 10% of the mean lesion size change after 1 year, according to Ruiz-Moreno et al.
4 Although for both applications the actual distribution of magnification differences will depend on the actual clinical population, the overall underestimation of true distances will likely remain due to the increasing prevalence of myopia.
47
To conclude, the PAROS method is able to correct for the scaling of fundus images and has been validated extensively. The method takes both complete ocular biometry and the camera setup into account, the latter of which is not considered by previous correction methods. In the described case series, magnification differences up to 50% were seen, showing the importance of correction for this scaling issue when fundus distance measurements are taken, such as in ocular radiation therapy treatment planning.
Supported in part by a grant from the Dutch Cancer Society (KWF, project number 13400).
Disclosure: L.J. Pors, None; C. Haasjes, None; L. van Vught, None; N.P. Hoes, None; G.P.M. Luyten, None; G.A. van Rijn, None; T.H.K. Vu, None; C.R.N. Rasch, Varian a Siemens Healthineers Company (F), RaySearch Laboratories (F); N. Horeweg, Varian a Siemens Healthineers Company (F), RaySearch Laboratories (F); J.-W.M. Beenakker, Varian a Siemens Healthineers Company (F), RaySearch Laboratories (F), Philips Healthcare (F)